CD4+ T-cell receptor repertoire (CD4+ TCR repertoire)

The CD4+ T-cell receptor (TCR) repertoire is the diverse collection of heterodimeric receptors expressed on helper T cells, specialized in recognizing antigenic peptides presented by Major Histocompatibility Complex (MHC) class II molecules (Janeway et al., Immunobiology, 2001). This recognition is a fundamental step in the adaptive immune response, as it facilitates the activation and differentiation of CD4+ T cells into effector subsets such as Th1, Th2, and Th17, which coordinate the body's defense against pathogens and tumors (Luckheeram et al., 2012, 'CD4+ T Cells: Differentiation and Functions'). In the context of vaccination, the TCR repertoire is the primary functional target; vaccines are designed to prime and expand specific TCR clones that recognize vaccine-derived peptides to establish long-term immunological memory (Sallusto et al., 2010, 'The Role of Memory T Cells in Humoral Immunity'). The diversity of this repertoire, generated through V(D)J recombination, allows for the recognition of a vast array of potential antigens, but also necessitates careful monitoring to avoid cross-reactivity with self-antigens (Woodsworth et al., 2013, 'The T cell repertoire: Diversity and its clinical implications'). Modern immunotherapies and vaccines increasingly utilize high-throughput TCR sequencing as a biomarker to evaluate the breadth and specificity of the immune response elicited by these treatments (Rosati et al., 2017, 'Overview of T-cell repertoire diversity').

Other names

CD4+ T-cell receptorMHC class II-restricted T-cell receptorsHelper T-cell receptor libraryAntigen-specific CD4+ TCRs

Vaccine-derived peptides are processed and presented by professional antigen-presenting cells (APCs) on MHC class II molecules. Specific TCRs within the CD4+ repertoire bind these peptide-MHC complexes, triggering signal transduction via the CD3 complex, which involves the phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs) and subsequent activation of downstream pathways like NFAT and NF-κB, leading to T-cell proliferation and differentiation (Smith-Garvin et al., 2009, 'T-cell activation').